 ft 08 92 uk compani news right doubl loss proteus  pre tax loss proteus intern usm quot specialist comput aid molecular model ration drug design doubl pound 1 27m pound 2 41m year march 31 compani announc right issu rais pound 12 2m net undertak number specif budget product develop plan mr kevin gilmor chairman year continu expans molecular model design facil consider cost incur busi develop work potenti aid hiv prophylact therapeut vaccin trial result encourag strive maintain ownership interest core proprietari product format joint ventur pursu genelab technolog relat potenti dna bind compound turnov reduc pound 3 000 pound 7 000 loss share 11 05p 5 92p right underwritten alli provinci secur 1 5 basi 280p share 